Etiopathological study of Vikrita Kleda with special reference to Laboratory Parameters
Not Applicable
- Conditions
- Health Condition 1: R688- Other general symptoms and signs
- Registration Number
- CTRI/2024/08/072391
- Lead Sponsor
- Dr ABDUL MUHITH
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
Willing to participate in the study.
Subjects having the clinical features mentioned for Kleda will be included.
Exclusion Criteria
Not willing to participate in the study.
Pregnant and lactating women.
Subjects with immunocompromised states like HIV, Tuberculosis, Hepatitis B & C etc.Subjects with malignancy.
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method For the establishment of a clear correlation between Vikrita Kleda and specific diseases, enabling a deeper understanding of the underlying pathological processes.Timepoint: One and half years
- Secondary Outcome Measures
Name Time Method Development of a framework for diagnosing and managing diseases related to Vikrita Kleda, based on Ayurvedic principles and practices.Timepoint: 1 and half years